Showing 1 - 10 of 27
The use of day case surgery has increased rapidly as an alternative to inpatient surgery. Little is known, however, about the value of day case surgery to patients. The aim of this paper was to develop a contingent valuation survey to investigate how individuals value the costs of shifting from...
Persistent link: https://www.econbiz.de/10005442636
Persistent link: https://www.econbiz.de/10012406833
Persistent link: https://www.econbiz.de/10005516197
Persistent link: https://www.econbiz.de/10005516272
The principal aim of this paper is to estimate a stochastic frontier cost function and an inefficiency effects model in the analysis of the primary health-care services purchased by the public authority and supplied by 180 providers in 1996 in Catalonia. The evidence from our sample does not...
Persistent link: https://www.econbiz.de/10005440539
This paper provides empirical evidence on the explanatory factors affecting introductory prices of new pharmaceuticals in a heavily regulated and highly subsidized market. We collect a data set consisting of all new chemical entities launched in Spain between 1997 and 2005, and model launch...
Persistent link: https://www.econbiz.de/10011048286
<Emphasis Type="Bold">Background: In many countries with generic reference pricing, generic producers and distributors compete by means of undisclosed discounts offered to pharmacies in order to reduce acquisition costs and to induce them to dispense their generic to patients in preference over others. <Emphasis Type="Bold">Objective: The...</emphasis></emphasis>
Persistent link: https://www.econbiz.de/10011000694
After decades of unsuccessfully trying to reduce drug spending in the Spanish National Health System through actions on prices and on prescribers, the co-payment established in mid-2012 led to a dramatic reduction in the use of drugs. The health effects of this reduction are not known. </AbstractSection>...
Persistent link: https://www.econbiz.de/10011000805
This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and...
Persistent link: https://www.econbiz.de/10011171320
Persistent link: https://www.econbiz.de/10010993969